Adverum Biotechnologies Inc. Stock
With 6 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 1.38 € the target price of 4 € shows a potential of 189.86% for Adverum Biotechnologies Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Adverum Biotechnologies Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Adverum Biotechnologies Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Adverum Biotechnologies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies Inc. | - | - | - | - | - | - | - |
| Ardelyx Inc. | 3.710% | 0.436% | -11.361% | 47.951% | 3.668% | -1.770% | - |
| Salarius Pharmaceuticals Inc. | -2.830% | -4.072% | 0.000% | -70.556% | -23.604% | -98.430% | -99.993% |
| Brainstorm Cell | -30.000% | -29.447% | -33.143% | -87.283% | 51.293% | -87.897% | - |
Comments
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $30.00 price target on the stock.
Show more
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target lowered by analysts at Mizuho from $40.00 to $22.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Show more
Ratings data for ADVM provided by MarketBeat